Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Cutting Edge: Protective Cell-Mediated Immunity to Listeria monocytogenes in the Absence of Myeloid Differentiation Factor 88

Sing Sing Way, Tobias R. Kollmann, Adeline M. Hajjar and Christopher B. Wilson
J Immunol July 15, 2003, 171 (2) 533-537; DOI: https://doi.org/10.4049/jimmunol.171.2.533
Sing Sing Way
* Pediatrics and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tobias R. Kollmann
* Pediatrics and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adeline M. Hajjar
†Immunology, University of Washington School of Medicine, Seattle, WA 98195
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher B. Wilson
* Pediatrics and
†Immunology, University of Washington School of Medicine, Seattle, WA 98195
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    IFN-γ production by CD8 (A) and CD4 T cells (B) from MyD88-deficient (myd88−/−) and control (myd88+/−) mice following stimulation with the indicated LM-specific peptides or no peptide control. Cells were obtained from indicated mice 7 days after infection with ActA-deficient LM. The numbers in the upper right quadrant indicate the mean percentages (±SE) of IFN-γ-producing CD8 or CD4 T cells. C, Total numbers of IFN-γ-producing CD8 and CD4 T cells per mouse spleen following stimulation with MHC class I- or class II-restricted LM-specific peptides. These data represent seven mice per group from two combined experiments. Bar, SE; ∗, statistically significant difference.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    A, Splenocytes from either MyD88-deficient (myd88−/−) or control (myd88+/+) mice immunized with ActA-deficient LM transfer protection. B, CD8 T cells mediate the protective effects of splenocytes from immunized MyD88-deficient mice. Saline or 6.0 × 107 of the indicated splenocytes were injected into naive C57BL/6 mice 1 h before i.v. infection with 1.0 × 105 CFUs of wt LM 10403s. CFUs of LM in either the spleen (○) or the liver (▵) of mice 3 days after infection were determined. The plot represents the data from five to seven mice per group combined from two separate experiments. Bar, geometric mean.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Immunization with ActA-deficient LM protects MyD88-deficient (myd88−/−) and control (myd88+/−) mice from infection with wt LM. CFUs of LM in either the spleen (○) or the liver (▵) of MyD88-deficient or control mice 3 days after i.v. challenge with 5.0 × 103 CFUs of wt LM 10403s. The plot represents the data from six to seven mice per group combined from two separate experiments. Bar, geometric mean.

Tables

  • Figures
    • View popup
    Table I.

    Cytokine production by LM-specific CD4 T cellsa

    myd88−/−myd88+/−p Value
    IFN-γ, unstimulated cells30.6 ± 30.691.2 ± 62.70.46
    IFN-γ, stimulated cells3085.6 ± 806.011589.4 ± 1427.6<0.001
    IL-4, unstimulated cellsn.d.n.d.n.a.
    IL-4, stimulated cellsn.d.n.d.n.a.
    • a Concentrations of IFN-γ and IL-4 in culture supernatants of splenocytes from MyD88-deficient (myd88−/−) and control (myd88+/−) mice following stimulation with the LM class II peptide LLO 189–201. Splenocytes were isolated from these mice 7 days after ActA-deficient LM infection. Data represent the mean (picograms per milliliter) ± SE from seven mice per group from two independent experiments. n.d., not detectable (≤ 37 pg/ml); n.a., not applicable.

PreviousNext
Back to top

In this issue

The Journal of Immunology: 171 (2)
The Journal of Immunology
Vol. 171, Issue 2
15 Jul 2003
  • Table of Contents
  • About the Cover
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cutting Edge: Protective Cell-Mediated Immunity to Listeria monocytogenes in the Absence of Myeloid Differentiation Factor 88
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cutting Edge: Protective Cell-Mediated Immunity to Listeria monocytogenes in the Absence of Myeloid Differentiation Factor 88
Sing Sing Way, Tobias R. Kollmann, Adeline M. Hajjar, Christopher B. Wilson
The Journal of Immunology July 15, 2003, 171 (2) 533-537; DOI: 10.4049/jimmunol.171.2.533

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cutting Edge: Protective Cell-Mediated Immunity to Listeria monocytogenes in the Absence of Myeloid Differentiation Factor 88
Sing Sing Way, Tobias R. Kollmann, Adeline M. Hajjar, Christopher B. Wilson
The Journal of Immunology July 15, 2003, 171 (2) 533-537; DOI: 10.4049/jimmunol.171.2.533
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Cutting Edge: SARS-CoV-2 Infection Induces Robust Germinal Center Activity in the Human Tonsil
  • Cutting Edge: T Cell Responses to B.1.1.529 (Omicron) SARS-CoV-2 Variant Induced by COVID-19 Infection and/or mRNA Vaccination Are Largely Preserved
  • Cutting Edge: Enhanced Antitumor Immunity in ST8Sia6 Knockout Mice
Show more CUTTING EDGE

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606